Skip to main content

Table 2 Predictors of HCM-related death and overall MACEs

From: Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand

Variables

HCM-Related Death

MACEs

Univariate Analysis

Univariate Analysis

Multivariate Analysis

Hazard Ratio

p Value

Hazard Ratio

p Value

Hazard Ratio

p Value

Age ≥ 65 years

0.78

0.66

2.01

0.01*

1.66

0.09

Female

1.24

0.65

2.33

< 0.01*

1.66

0.11

BSA ≤ 1.5 m2

2.03

0.11

1.97

0.01*

1.70

0.08

NYHA III-IV

1.36

0.58

3.00

< 0.01*

1.27

0.55

Heart rate > 90/min

2.56

0.07

3.05

< 0.01*

2.18

0.04**

Family History of SCD

0.88

0.73

1.03

0.94

  

AF on ECG

1.83

0.28

2.05

0.05

2.81

0.01**

Heart failure at presentation

1.32

0.59

3.44

< 0.01*

2.93

< 0.01**

Maximal septal thickness ≥ 25 mm

1.15

0.80

0.97

0.94

  

LVEF < 60%

0.60

0.36

1.75

0.12

  

Septal reductive therapy

0.58

0.59

1.12

0.65

  
  1. AF atrial fibrillation, BSA body surface area, ECG electrocardiography, LVEF left ventricular ejection fraction; MR mitral regurgitation, NYHA New York Heart Association, SCD sudden cardiac death